相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 954, 2018)
Ali H. Mokdad
LANCET NEUROLOGY (2021)
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention
Messoud Ashina et al.
CEPHALALGIA (2021)
Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study
Anastasia Bougea et al.
NEUROLOGICAL SCIENCES (2020)
Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis
Simona D. Frederiksen et al.
HEADACHE (2020)
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety
John D. Markman et al.
PAIN (2020)
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Karen D. Davis et al.
NATURE REVIEWS NEUROLOGY (2020)
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
Cecilia Rustichelli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
Rosaria Greco et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine
Patrizia Ferroni et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Migraine: Genetic Variants and Clinical Phenotypes
Innocenzo Rainero et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Putative salivary biomarkers useful to differentiate patients with fibromyalgia
Federica Ciregia et al.
JOURNAL OF PROTEOMICS (2019)
Promote Biomarker Discovery by Identifying Homogenous Primary Headache Subgroups
Simona Denise Frederiksen
HEADACHE (2019)
Migraine and cluster headache show impaired neurosteroids patterns
Angela Koverech et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
Thomas Dresler et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls
Katharina Kamm et al.
CEPHALALGIA (2019)
Migraine: Experimental Models and Novel Therapeutic Approaches
Giuseppe Tardiolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study
Luca Gallelli et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine
Elisa Dini et al.
TOXINS (2019)
Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications
Patrizia Ferroni et al.
CURRENT MEDICINAL CHEMISTRY (2019)
The IASP classification of chronic pain for ICD-11: chronic secondary headache or orofacial pain
Rafael Benoliel et al.
PAIN (2019)
CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
Clara Dominguez et al.
HEADACHE (2018)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal
Mi Ji Lee et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The serum level of inflammatory markers in chronic and episodic migraine: a case-control study
Fahimeh Martami et al.
NEUROLOGICAL SCIENCES (2018)
Glutamate and Its Receptors as Therapeutic Targets for Migraine
Jan Hoffmann et al.
NEUROTHERAPEUTICS (2018)
Serum apolipoprotein E may be a novel biomarker of migraine
Naoki Yuasa et al.
PLOS ONE (2018)
What Are We Missing in the Diagnostic Criteria for Migraine?
Amanda Tinsley et al.
CURRENT PAIN AND HEADACHE REPORTS (2018)
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
Casper Emil Christensen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Joseph Raymond Zunt et al.
LANCET NEUROLOGY (2018)
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Lars Jacob Stovner et al.
LANCET NEUROLOGY (2018)
Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study
Chun-Yu Cheng et al.
CEPHALALGIA (2018)
Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
Mona K. Patel et al.
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY (2018)
Chronic migraine patients show cognitive impairment in an extended neuropsychological assessment
Karen S. Ferreira et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2018)
Salivary glutamate is elevated in individuals with chronic migraine
Ji Hye Nam et al.
CEPHALALGIA (2018)
Investigating the role of adipokines in chronic migraine
Elisa Rubino et al.
CEPHALALGIA (2017)
Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
Robin M. van Dongen et al.
CEPHALALGIA (2017)
Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal
Licia Grazzi et al.
NEUROLOGICAL SCIENCES (2017)
Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods
Hjalte H. Andersen et al.
MOLECULAR NEUROBIOLOGY (2016)
Adipokines and Migraine: A Systematic Review
B. Lee Peterlin et al.
HEADACHE (2016)
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine
Padhraig Gormley et al.
NATURE GENETICS (2016)
MicroRNA profiling in migraine without aura: Pilot study
Emmanuele Tafuri et al.
ANNALS OF MEDICINE (2015)
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine
Monica Neri et al.
CEPHALALGIA (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
Vascular biomarkers in migraine
Gretchen E. Tietjen et al.
CEPHALALGIA (2015)
C-reactive protein and migraine. Facts or speculations?
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine
Roger Cady et al.
HEADACHE (2014)
CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
Eva Cernuda-Morollon et al.
HEADACHE (2014)
Increased serum levels of adiponectin in migraine
Halina Duarte et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Inflaming the need for migraine biomarkers
Richard B. Lipton
NEUROLOGY (2014)
Chronic migraine
Todd J. Schwedt
BMJ-BRITISH MEDICAL JOURNAL (2014)
Latin American consensus on guidelines for chronic migraine treatment
Alex Rodrigo Espinoza Giacomozzi et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2013)
Glutamate oxaloacetate transaminase: A new key in the dysregulation of glutamate in migraine patients
Francisco Campos et al.
CEPHALALGIA (2013)
Biomarkers Associated With Migraine and Their Potential Role in Migraine Management
Paul Durham et al.
HEADACHE (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
Increased matrix metalloproteinase activity is associated with migraine and migraine-related metabolic dysfunctions
C. Bernecker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Oxidative stress is associated with migraine and migraine-related metabolic risk in females
C. Bernecker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)
Michael Stokes et al.
HEADACHE (2011)
Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients
M-U Jang et al.
ORAL DISEASES (2011)
Salivary alpha amylase activity in migraine patients
Guler Bugdayci et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2010)
No arguments for increased endothelial nitric oxide synthase activity in migraine based on peripheral biomarkers
Bart J. Van der Schueren et al.
CEPHALALGIA (2010)
Migraine prevalence by age and sex in the United States: A life-span study
T. W. Victor et al.
CEPHALALGIA (2010)
Effective prophylactic treatments of migraine lower plasma glutamate levels
A. Ferrari et al.
CEPHALALGIA (2009)
Advanced neuroimaging of migraine
Todd J. Schwedt et al.
LANCET NEUROLOGY (2009)
Low leptin levels in migraine: A case control study
Baburhan Guldiken et al.
HEADACHE (2008)
Oligomerization state-dependent elevations of adiponectin in chronic daily headache
B. Lee Peterlin et al.
NEUROLOGY (2008)
Voxel-based morphometry reveals gray matter abnormalities in migraine
Walter Valfre et al.
HEADACHE (2008)
分享论文
